Human monocytotropic ehrlichiosis

From WikiMD's WELLNESSPEDIA

(Redirected from HME)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Human monocytotropic ehrlichiosis
Micrograph of Ehrlichia chaffeensis in a monocyte
Synonyms Human monocytic ehrlichiosis
Pronounce N/A
Specialty N/A
Symptoms Fever, headache, malaise, muscle pain
Complications Meningitis, respiratory failure, septic shock
Onset 1 to 2 weeks after tick bite
Duration Variable
Types N/A
Causes Ehrlichia chaffeensis
Risks Tick exposure, outdoor activities
Diagnosis Serology, PCR
Differential diagnosis Rocky Mountain spotted fever, anaplasmosis, leptospirosis
Prevention Tick bite prevention, protective clothing
Treatment Doxycycline
Medication Doxycycline
Prognosis Generally good with treatment
Frequency Rare
Deaths Rare, but possible if untreated


Human Monocytotropic Ehrlichiosis is a tick-borne disease caused by the bacterium Ehrlichia chaffeensis. This disease is primarily transmitted to humans by the Lone Star tick (Amblyomma americanum).

Symptoms[edit]

The symptoms of Human Monocytotropic Ehrlichiosis typically appear within 1-2 weeks following the bite of an infected tick. Symptoms can include:

Diagnosis[edit]

Diagnosis of Human Monocytotropic Ehrlichiosis is based on clinical signs and symptoms, and can later be confirmed with specialized confirmatory laboratory tests. Treatment should never be delayed pending the receipt of laboratory test results, or be withheld on the basis of an initial negative laboratory result.

Treatment[edit]

The treatment of choice for Human Monocytotropic Ehrlichiosis is Doxycycline. Doxycycline is most effective at preventing severe complications from the disease if it is started early in the course of illness.

Prevention[edit]

Prevention of Human Monocytotropic Ehrlichiosis primarily involves avoiding areas where ticks are found and using insect repellents.

See Also[edit]

Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Human_monocytotropic_ehrlichiosis&oldid=6546858"